CS logo
small CS logo
Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,

Guangzhou, Guangdong, China

About Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Sun Yat-sen University
6
Ming Zhao
1
Total Rows: 2

Clinical Trials at Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,


During the past decade, Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center, conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111441100000000Started TrialsCompleted Trails20202021202220230246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC
2020-12-21
2025-12-18
Recruiting
120
Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma
2022-04-11
2023-12-30
Recruiting
30
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC
2021-12-20
2025-12-01
Recruiting
150
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
2022-05-18
2025-02-28
Recruiting
299
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
2022-03-28
2025-02-28
Recruiting
426
Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma
2022-10-16
2026-01-01
Recruiting
50
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma
2023-03-01
2025-09-01
Not yet recruiting
100

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsSun Yat-sen University: 6Sun Yat-sen University: 6Ming Zhao: 1Ming Zhao: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,


According to Clinical.Site data, the most researched conditions in "Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center," are "Hepatocellular Carcinoma" (5 trials), "Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma" (1 trials) and "Recurrent Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center," in a lesser frequency.

Clinical Trials Intervention Types at Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,


Most popular intervention types in "Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center," are "Drug" (4 trials), "Procedure" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Ablation" (1 trials), "Durvalumab" (1 trials), "Hepatic artery infusion chemotherapy(HAIC)" (1 trials), "Immune checkpoint inhibitor" (1 trials) and "Lenvatinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,


The vast majority of trials in "Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center," are 7 trials for "All" genders.

Clinical Trials Status at Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,


Currently, there are NaN active trials in "Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,". 1 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Phase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusRecruiting: 6Recruiting: 6Not yet recruiting: 1Not yet recruiting: 1